Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
GSK and Abbott Announce Leadership Changes in Key Roles
February 19, 2025
Company
Medtronic Q3 Earnings Show 4.1% Organic Growth, Driven by Cardiac Ablation
February 19, 2025
Company
Deals
QuantumPharm and Hengjian Launch GBA AI+ Innovation Consortium
February 19, 2025
Company
Deepwise Information Integrates DeepSeek into Medical Data Platform
February 19, 2025
Company
Weimai Qingtong Medical Technology Completes Tens of Millions Yuan B+ Round
February 19, 2025
Company
Drug
InnoCare Pharma Receives NMPA Approval for Mesutoclax Phase III Study in CLL/SLL
February 18, 2025
Company
Drug
Hengrui Pharma’s HR19034 Eye Drops for Myopia Delay Accepted by NMPA
February 18, 2025
Company
Drug
Gan & Lee Pharmaceuticals Doses First Patient in GZR4 Phase III Study for Diabetes
February 18, 2025
Company
Deals
Stedical Scientific Raises RMB100M in Series B Financing for Global Expansion
February 18, 2025
Company
Drug
Zelgen Biopharmaceuticals’ ZG005 Bispecific Antibody Receives NMPA Approval for Biliary Tract Cancer Trials
February 18, 2025
Company
Drug
Bristol-Myers Squibb Releases Five-Year Data on Sotyktu’s Long-Term Efficacy and Safety
February 18, 2025
Company
Drug
Wanbangde New Building Materials’ Mecobalamin Earns FDA Orphan Drug Designation for ALS
February 18, 2025
1
2
…
246
247
248
249
250
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?